Rodríguez-Serrano F - Search Results

1

5-Fluorouracil derivatives: a patent review.

Álvarez P, Marchal JA, Boulaiz H, Carrillo E, Vélez C, Rodríguez-Serrano F, Melguizo C, Prados J, Madeddu R, Aranega A. Álvarez P, et al. Expert Opin Ther Pat. 2012 Feb;22(2):107-23. doi: 10.1517/13543776.2012.661413. Epub 2012 Feb 14. Expert Opin Ther Pat. 2012. PMID: 22329541 Review.

2

Release of alpha-actin into serum after skeletal muscle damage.

Martínez-Amat A, Boulaiz H, Prados J, Marchal JA, Padial Puche P, Caba O, Rodríguez-Serrano F, Aránega A. Martínez-Amat A, et al. Br J Sports Med. 2005 Nov;39(11):830-4. doi: 10.1136/bjsm.2004.017566. Br J Sports Med. 2005. PMID: 16244192 Free PMC article.

3

Induction of drug resistance in embryonal rhabdomyosarcoma treated with conventional chemotherapy is associated with HLA class I increase.

Prados J, Melguizo C, Fernández JE, Carrillo E, Marchal JA, Boulaiz H, Martínez A, Rodriguez-Serrano F, Aránega A. Prados J, et al. Neoplasma. 2006;53(3):226-31. Neoplasma. 2006. PMID: 16652192

4

Differentiation: an encouraging approach to anticancer therapy.

Marchal JA, Rodríguez-Serrano F, Campos J, Madeddu R, Boulaiz H, Martínez-Amat A, Carrillo E, Caba O, Prados JC, Vélez C, Melguizo C, Montella A, Aránega A. Marchal JA, et al. Ital J Anat Embryol. 2006 Jan-Mar;111(1):45-64. Ital J Anat Embryol. 2006. PMID: 16736717 Review.

5

Prognostic value of RT-PCR tyrosinase detection in peripheral blood of melanoma patients.

Carrillo E, Prados J, Marchal JA, Boulaiz H, Martínez A, Rodríguez-Serrano F, Caba O, Serrano S, Aránega A. Carrillo E, et al. Dis Markers. 2006;22(3):175-81. doi: 10.1155/2006/462065. Dis Markers. 2006. PMID: 16788251 Free PMC article.

6

A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells.

Marchal JA, Núñez MC, Suárez I, Díaz-Gavilán M, Gómez-Vidal JA, Boulaiz H, Rodríguez-Serrano F, Gallo MA, Espinosa A, Aránega A, Campos JM. Marchal JA, et al. Breast Cancer Res Treat. 2007 Nov;105(3):237-46. doi: 10.1007/s10549-006-9450-2. Epub 2006 Nov 24. Breast Cancer Res Treat. 2007. PMID: 17124554

7

Exogenous nucleosides modulate proliferation of rat intestinal epithelial IEC-6 cells.

Rodríguez-Serrano F, Marchal JA, Ríos A, Martínez-Amat A, Boulaiz H, Prados J, Perán M, Caba O, Carrillo E, Hita F, Aránega A. Rodríguez-Serrano F, et al. J Nutr. 2007 Apr;137(4):879-84. doi: 10.1093/jn/137.4.879. J Nutr. 2007. PMID: 17374648 Free article.

8

5-fluorouracil derivatives induce differentiation mediated by tubulin and HLA class I modulation.

Marchal JA, Boulaiz H, Rodríguez-Serrano F, Peran M, Carrillo E, Vélez C, Domínguez J, Gómez-Vidal JA, Campos J, Gallo MA, Espinosa A, Aránega A. Marchal JA, et al. Med Chem. 2007 May;3(3):233-9. doi: 10.2174/157340607780620671. Med Chem. 2007. PMID: 17504194

9

Antiproliferative activity, cell-cycle dysregulation, and cellular differentiation: salicyl- and catechol-derived acyclic 5-fluorouracil O,N-acetals against breast cancer cells.

Marchal JA, Rodríguez-Serrano F, Caba O, Aránega A, Gallo MA, Espinosa A, Campos JM. Marchal JA, et al. ChemMedChem. 2007 Dec;2(12):1814-21. doi: 10.1002/cmdc.200700142. ChemMedChem. 2007. PMID: 17969215

10

Synthesis and anticancer activity of (R,S)-9-(2,3-dihydro-1,4-benzoxathiin-3-ylmethyl)-9H-purines.

Díaz-Gavilán M, Conejo-García A, Cruz-López O, Núñez MC, Choquesillo-Lazarte D, González-Pérez JM, Rodríguez-Serrano F, Marchal JA, Aránega A, Gallo MA, Espinosa A, Campos JM. Díaz-Gavilán M, et al. ChemMedChem. 2008 Jan;3(1):127-35. doi: 10.1002/cmdc.200700180. ChemMedChem. 2008. PMID: 18022976

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page